BioTech Mag Search: Neurosciences
Preliminary Minimum Reporting Requirements for In-Vivo Neural Interface Research: I. Implantable Neural Interfaces
8 days ago - By EMBS
The pace of research and development in neuroscience, neurotechnology, and neurorehabilitation is rapidly accelerating, with the number of publications doubling every 4.2 years. Maintaining this progress requires technological standards and scientific reporting guidelines to provide frameworks for communication and interoperability. The present lack of such neurotechnology standards limits the transparency, repro-ducibility, and meta-analysis of this...
Read more ...
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Astrocytes Derived from Patients with Bipolar Disorder Malfunction
Bionano Genomics: Document Control Associate
Bionano Genomics: The Document Control Associate will play a critical role in implementation of the Bionano Genomics Quality Management System. In this role th... 92123, San...
OmicLoupe: facilitating biological discovery by interactive exploration of...
Abstract Background Visual exploration of gene product behavior across multiple omic datasets can pinpoint technical limitations in data and reveal biological trends. Still...
Cidara Therapeutics: Research Associate, In Vivo
Cidara Therapeutics: Position Summary Animal technician to conduct in vivo studies in mice at our local vivarium. Will also be required to prepare and work with BSL2 l... San...
Scientists discover how microorganisms evolve cooperative behaviors
New research sheds light on how interspecies interactions arise, evolve and are maintained. The results provide a new window to understand the key roles of these interactions...
Seeing is believing: a visualization toolbox to enhance selection efficiency...
Abstract The emerging and promising biotechnology methodology of CRISPR/Cas9 gene‐editing is revolutionizing crop improvement. However, the low‐efficiency, time‐consuming, and...
Developing a Nicotiana benthamiana transgenic platform for high‐value...
Summary To engineer Nicotiana benthamiana to produce novel diterpenoids, we first aimed to increase production of the diterpenoid precursor geranylgeranyl pyrophosphate by...
Generation of novel self‐incompatible Brassica napus by CRISPR/Cas9
Abstract Self‐incompatibility is a genetic mechanism that prevents inbreeding in hermaphrodite angiosperms via the rejection of self‐pollen. SI lines facilitate the utilization...
Advanced domestication: harnessing the precision of gene editing in crop...
Summary Human population growth has increased the demand for food crops, animal feed, biofuel and biomaterials, all the while climate change is impacting environmental growth...
BlackRock powers Exscientia to $100M series C round to fund autonomous drug...
BlackRock powers Exscientia to $100M series C round to fund autonomous drug design ntaylor Thu, 03/04/2021 - 08:25